Ikeda Tadashi
Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 160-8582, Japan,
Surg Today. 2014 Nov;44(11):2015-21. doi: 10.1007/s00595-013-0783-2. Epub 2013 Nov 20.
There is no consensus regarding the strategy for managing the regional lymph nodes in patients with local breast cancer recurrence. This paper reviews the updated data on re-sentinel lymph node biopsy (re-SLNB) after previous surgery. The identification rate of re-SLNB varied from 29 to 100 % (mean 67 %). The success rate of re-SLNB depends on the method used for the previous axillary surgery and the number of lymph nodes harvested. Re-SLNB may be feasible even after mastectomy. A relationship between post-operative radiotherapy and identification of re-SLNB was not seen. A longer disease-free interval may correlate with a lower identification rate, but this finding is not definitive. Based on data regarding back-up dissection after re-SLNB, the accuracy of re-SLNB may be as good as SLNB in primary cases. Altered lymphatic drainage was reported in 2-89 % (mean 32 %) of cases. Because the altered lymphatic drainage can be detected only by lymphoscintigraphy, the radioisotope method, followed by lymphoscintigraphy, should be used. There are not many reported cases of axillary recurrence after re-SLNB, and the follow-up periods have been short. Because re-SLNB cases have a wide variety of backgrounds, it is necessary to accumulate a larger number of cases and to obtain data from longer follow-up period in order to make clear recommendations.
对于局部乳腺癌复发患者区域淋巴结的管理策略,目前尚无共识。本文回顾了既往手术后再次前哨淋巴结活检(re-SLNB)的最新数据。re-SLNB的识别率在29%至100%之间(平均67%)。re-SLNB的成功率取决于既往腋窝手术所采用的方法以及所获取的淋巴结数量。即使在乳房切除术后,re-SLNB也可能可行。未发现术后放疗与re-SLNB识别之间存在关联。较长的无病生存期可能与较低的识别率相关,但这一发现并不确定。基于re-SLNB后补救性清扫的数据,re-SLNB的准确性可能与原发性病例中的SLNB一样好。据报道,2%至89%(平均32%)的病例存在淋巴管引流改变。由于只有通过淋巴闪烁造影才能检测到淋巴管引流改变,因此应采用放射性同位素方法,随后进行淋巴闪烁造影。re-SLNB后腋窝复发的报道病例不多,且随访期较短。由于re-SLNB病例的背景各不相同,有必要积累更多病例并从更长的随访期获取数据,以便提出明确的建议。